Is ClearPoint Neuro, Inc. (CLPT) Halal?

NASDAQ Healthcare United States $270M
✓ HALAL
Confidence: 95/100
ClearPoint Neuro, Inc. (CLPT) is Halal under 3 of 5 Shariah screening standards, including AAOIFI Standard 21. With a debt ratio of just 1.2% against the AAOIFI threshold of 30%, ClearPoint Neuro, Inc. comfortably passes the key financial ratio tests. The company operates in the Healthcare sector (Medical Devices), which is not a prohibited industry under Islamic finance principles.

Shariah Screening — 5 Standards

Based on financial data from December 2024

Standard Debt Ratio Cash Ratio Receivables Income Status
AAOIFI 1.2%
/ 30%
6.8%
/ 30%
1.6%
/ 30%
2.78%
/ 5%
✓ HALAL
DJIM 1.2%
/ 33%
6.8%
/ 33%
1.6%
/ 33%
2.78%
/ 5%
✓ HALAL
MSCI 9.1%
/ 33%
51.3%
/ 33%
12.0%
/ 33%
2.78%
/ 5%
✗ NOT HALAL
S&P 1.2%
/ 33%
6.8%
/ 33%
1.6%
/ 33%
2.78%
/ 5%
✓ HALAL
FTSE 9.1%
/ 33%
51.3%
/ 33%
12.0%
/ 50%
2.78%
/ 5%
✗ NOT HALAL

Financial Highlights

EPS
$-0.90
P/B Ratio
9.5
EV/EBITDA
-13.1
EV: $281M
Revenue
$31M
Growth: 34.0%
Beta
1.1
Average volatility
Current Ratio
5.9

Profitability

Gross Margin 61.4%
Operating Margin -50.4%
Net Margin -69.1%
Return on Equity (ROE) -95.6%
Return on Assets (ROA) -20.4%

Cash Flow & Balance Sheet

Operating Cash Flow-$9M
Free Cash Flow-$9M
Total Debt$4M
Debt-to-Equity207.8
Current Ratio5.9
Total Assets$39M

Price & Trading

Last Close$9.39
50-Day MA$12.36
200-Day MA$14.22
Avg Volume820K
Beta1.1
52-Week Range
$8.63
$30.10

About ClearPoint Neuro, Inc. (CLPT)

CEO
Mr. Joseph Michael Burnett
Employees
172
Sector
Healthcare
Industry
Medical Devices
Country
United States
Exchange
NASDAQ
Market Cap
$270M
Currency
USD

ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States. The company offers ClearPoint systems, such as ClearPoint hardware, which includes head fixation frame, computer workstation, and in-room monitor; and ClearPoint disposables, which consist of SmartFrame trajectory device, a hand controller and related accessories, and its SmartFlow Neuro cannula. It also provides ClearPoint software, which guides the physician in surgical planning, device alignment, navigation to the target, and procedure monitoring; ClearPoint Prism Neuro laser therapy system to necrotize or coagulate soft tissue; and IRRAflow system, an active fluid exchange platform. In addition, the company offers consulting services to its pharmaceutical and other medical technology partners, such as benchtop testing, preclinical studies, clinical trial support, regulatory consultation, and translation from the preclinical to the clinical setting. It has licenses and collaboration agreements with Koninklijke Philips N.V., UCB Biopharma SRL, Clinical Laserthermia Systems AB, University of California, San Francisco, and NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

Purification Calculator

As a halal stock with 2.78% impermissible income, you need to purify your dividends.

Enter your dividends to calculate purification amount

Related Halal Stocks in Healthcare

Frequently Asked Questions

Is ClearPoint Neuro, Inc. (CLPT) halal to invest in?

Based on our screening using AAOIFI Standard 21 (the strictest methodology), ClearPoint Neuro, Inc. is Halal. The company passes all financial ratio thresholds for debt, cash, receivables, and impermissible income. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.

What is ClearPoint Neuro, Inc.'s debt ratio?

ClearPoint Neuro, Inc.'s debt ratio is 1.2% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 9.1%.

Does ClearPoint Neuro, Inc. require dividend purification?

Yes, ClearPoint Neuro, Inc. has an impermissible income ratio of 2.78%, which means 2.78% of any dividends received should be donated to charity as purification. This is because a small portion of the company's revenue comes from non-Shariah-compliant sources.

What are ClearPoint Neuro, Inc.'s key financial metrics?

ClearPoint Neuro, Inc. has a market capitalization of $270M, and revenue of $31M. The company maintains a gross margin of 61.4% and a net margin of -69.1%. Return on equity stands at -95.6%.

How often is the screening data updated?

Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.

Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.